The opportunity
A pulping and aseptic-filling line that converts ripe and surplus mango into sterile puree or concentrate, packed in 215 kg drums that need no cold chain. It decouples revenue from the harvest calendar — you process a year's fruit in the 10–12 week season and sell it over the following 12 months. Pakistan already exports aseptic pulp; we'd compete on captive raw-material cost and premium Chaunsa/Anwar Ratol quality.
Revenue lines
- ▸ Aseptic mango pulp / puree (215 kg bag-in-drum)
- ▸ Mango concentrate (higher Brix, cheaper to freight)
- ▸ Canned pulp (foodservice / private label)
- ▸ Buyers: juice & beverage, dairy, ice-cream, baby food, ingredient companies
Why now
- ● Pakistan is the ~5th-largest global mango exporter, but the vast majority ships as fresh fruit — industry bodies have long cited a large untapped pulp-export opportunity.
- ● Aseptic pulp ships ambient (no cold chain), which is why it's the proven, lower-risk Pakistani export format.
- ● The same 30–40% of fruit lost post-harvest becomes premium feedstock for pulp — free-to-cheap raw material.
- ● Premium Multan-belt varieties (Chaunsa, Anwar Ratol) differentiate our pulp from India's commodity Totapuri floor.
Indicative economics
All figures are indicative planning ranges — confirmed jointly during due diligence, not a guaranteed return.
Capital requirement
Indicative ~$0.7–1.4M small line; ~$2.5–6M European medium line
A small aseptic line on Chinese/Indian machinery sits around $0.7–1.4M all-in (land already owned); an export-grade European line (Italian/German aseptic filler + steriliser) runs materially higher. The aseptic filler and steriliser — not the pulper — drive the cost. These are planning-grade estimates; a real vendor quotation is required before financing.
How it earns
- ▸ Aseptic pulp sells FOB Karachi at roughly $900–1,300/tonne depending on variety and grade.
- ▸ About 3.5–4 kg of fruit makes 1 kg of pulp; cheap captive fruit is what makes the margin work.
- ▸ Concentrate cuts freight per unit of sugar; canned/pouch opens foodservice and private-label channels.
Margin logic
Sector data indicates ~25–35% gross and ~10–15% net margins — commodity-processing economics where raw-material cost decides viability. Owning the fruit is precisely what shifts that from marginal to attractive.
Payback thinking
A small aseptic plant could target a ~4–7 year payback; a European medium plant is a longer, more capital-intensive bet that needs committed offtake to de-risk. We'd start small and phase up.
Plant & machinery
Washing, sorting & blanching line
Cleans and prepares fruit; steam blancher softens for pulping.
Pulper / de-stoner + refiner + homogeniser
Extracts smooth puree and removes stone/skin fragments.
Evaporator (optional)
Concentrates pulp to higher Brix for concentrate product and cheaper freight.
Tubular steriliser + aseptic bag-in-drum filler
The heart of the line — sterilises and fills 215 kg drums for ambient, 18–24 month shelf life.
Boiler + ambient warehouse
Steam supply and simple ambient storage (no cold chain needed for aseptic).
How it works, end to end
- 1Receive ripe & surplus fruit within hours of picking — freshness protects pulp colour and grade.
- 2Wash, blanch, then pulp and de-stone; refine and homogenise to a smooth puree.
- 3Optionally evaporate to concentrate for higher Brix.
- 4Sterilise thermally, then aseptically fill into sterile 215 kg bag-in-drum.
- 5Store ambient and ship FOB Karachi to juice, dairy and ingredient buyers.
Why partner with MMA Farms
- ✦ Raw material is 70–80% of operating cost — owning the orchard removes that markup and is the difference between 10% and 25% net margin.
- ✦ Fruit is processed within hours of picking, at the orchard, before summer heat runs down the shelf-life clock — better colour and grade.
- ✦ Premium Chaunsa / Anwar Ratol varieties command more than India's commodity Totapuri floor.
- ✦ Land already owned; existing sales and export relationships to build on.
- ✦ Aseptic monetises the same cull fruit that fresh export throws away.
Risks & how we manage them
We'd rather be straight about the risks now than surprise you later. Here's our honest view.
⚠ Capital intensity
How we manage it: Start with a small aseptic line, not a European mega-plant; scale only against committed offtake.
⚠ Entrenched competition (established Pakistani pulp exporters)
How we manage it: We don't compete on scale — we compete on captive raw-material cost and premium variety, and target buyers who value quality and provenance.
⚠ Export compliance (BRCGS / IFS / Halal audits)
How we manage it: Certification is scoped and budgeted up front as the real key to EU/UK retail access.
⚠ Seasonal working capital (buy a year's fruit in 3 months)
How we manage it: Structured seasonal financing and phased buying; the aseptic inventory itself is bankable collateral.
Investor questions
How is this different from the dried-mango plant?+
Dried mango is roughly an order of magnitude cheaper and lower-risk — a great entry point. Aseptic pulp is more capital-intensive but has a higher ceiling and a larger, established export market. Both rest on the same foundation: our owned orchard and the fruit that's otherwise wasted. Many investors start with dehydration and grow into pulp.
Doesn't Pakistan already have big pulp exporters?+
Yes — and we're honest that this is a competitive, established segment, not a new category. Our edge isn't out-scaling them; it's captive raw material at cost and premium Multan varieties. We'd target a defensible niche rather than the commodity floor.
Why aseptic rather than frozen?+
Aseptic pulp ships at ambient temperature with an 18–24 month shelf life — no cold chain, which matters given Pakistan's power reliability. Frozen (IQF) fetches a higher price but carries cold-chain cost and risk; we'd treat IQF as a later phase once the pulp line and buyer relationships are proven.
What will you commit to on returns?+
Nothing fixed. The figures here are indicative sector ranges, not promises. We'd build a transparent model together, backed by real vendor quotes and ideally a letter of intent from a buyer, before anyone commits capital.